These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6287887)

  • 21. Letter: Preparation and curarimimetic activity of (+)-isotubocurarine.
    Soine TO; Naghaway J
    J Pharm Sci; 1974 Oct; 63(10):1643-4. PubMed ID: 4279984
    [No Abstract]   [Full Text] [Related]  

  • 22. Dimethyl-1-curine dimethochloride--an alternative for d-tubocurarine chloride.
    Wu J; Xie FS
    Chin Med J (Engl); 1987 Mar; 100(3):173-6. PubMed ID: 2957178
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of metocurine in humans with and without renal failure.
    Brotherton WP; Matteo RS
    Anesthesiology; 1981 Sep; 55(3):273-6. PubMed ID: 7023284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative clinical pharmacokinetics of tubocurarine, gallamine, alcuronium and pancuronium.
    Buzello W; Agoston S
    Anaesthesist; 1978 Jul; 27(7):313-8. PubMed ID: 150804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH
    Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metocurine requirements and plasma concentrations in burned paediatric patients.
    Martyn JA; Goudsouzian NG; Matteo RS; Liu LM; Szyfelbein SK; Kaplan RF
    Br J Anaesth; 1983 Apr; 55(4):263-8. PubMed ID: 6220728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dose-effect relationship of metocurine: EMG versus MMG.
    Eisenkraft JB
    Anesthesiology; 1988 Nov; 69(5):807-8. PubMed ID: 2973267
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of ether and fluorothane on the comparative sensitivity of muscles to anatruxonium and D-tubocurarine chloride].
    Lepakhin VK
    Farmakol Toksikol; 1970; 33(5):538-42. PubMed ID: 4321818
    [No Abstract]   [Full Text] [Related]  

  • 29. The autonomic margins of safety of metocurine and d-tubocurarine in the cat.
    Savarese JJ
    Anesthesiology; 1979 Jan; 50(1):40-6. PubMed ID: 83803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New curare-like agents.
    Kharkevich DA
    J Pharm Pharmacol; 1974 Mar; 26(3):153-65. PubMed ID: 4151073
    [No Abstract]   [Full Text] [Related]  

  • 31. Resistance to metocurine-induced neuromuscular blockade in patients receiving phenytoin.
    Ornstein E; Matteo RS; Young WL; Diaz J
    Anesthesiology; 1985 Sep; 63(3):294-8. PubMed ID: 3161430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Neuromuscular and cardiovascular studies with dimethyl tubocurarine in anaesthetized cats, rhesus monkeys and man.
    Chapple DJ; Enderby DH; Hughes R; Payne JP
    Br J Pharmacol; 1976 Mar; 56(3):354P-355P. PubMed ID: 130951
    [No Abstract]   [Full Text] [Related]  

  • 33. Study of the reversal effect of NF449 on neuromuscular blockade induced by d-tubocurarine.
    Su TR; Hung YS; Huang SS; Su HH; Su CC; Hsiao G; Chen YH; Lin MJ
    Life Sci; 2011 Jun; 88(23-24):1039-46. PubMed ID: 21453711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of the elimination and neuromuscular blocking effect of d-tubocurarine in man.
    Gibaldi M; Levy G; Hayton W
    Anesthesiology; 1972 Mar; 36(3):213-8. PubMed ID: 5011414
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular and neuromuscular effects of Org NC 45, pancuronium, metocurine, and d-tubocurarine in dogs.
    Booij LH; Edwards RP; Sohn YJ; Miller RD
    Anesth Analg; 1980 Jan; 59(1):26-30. PubMed ID: 7188662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Electromyographic analysis of the mechanism governing the action of curare-like agents].
    Fisenko VP
    Farmakol Toksikol; 1972; 35(3):284-7. PubMed ID: 4340074
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of shaking on the sensitivity of neuromuscular transmission in vitro to d-tubocurarine and neomycin in mice.
    Nishimura M; Ikegami M; Taquahashi Y; Satoh E; Shimizu Y
    J Peripher Nerv Syst; 1998; 3(1):63-8. PubMed ID: 10959239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine.
    Miller RD; Larson CP; Way WL
    Anesthesiology; 1972 Nov; 37(5):503-9. PubMed ID: 4263447
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical pharmacology of muscle relaxants in patients with burns.
    Martyn J; Goldhill DR; Goudsouzian NG
    J Clin Pharmacol; 1986; 26(8):680-5. PubMed ID: 2947935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fading responses in the evoked EMG after rocuronium in cats.
    Shiraishi H; Suzuki H; Suzuki T; Katsumata N; Ogawa S
    Can J Anaesth; 1992 Dec; 39(10):1099-104. PubMed ID: 1361162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.